Additionally, AML cells with a mutation in the KMT2A/MLL gene exhibit higher CX3CR1 expression, while mutations in FLT3 and NPM1 do not appear to affect CX3CR1 expression levels [123]. This evidence concerns the gene FLT3 and acute myeloid leukemia.